Reagenics Research

Company Overview

Snapshot

Founded in February 2019 by Michael Kagan, Reagenics Research operates with 1–10 employees. The company has secured $3 million in total capital raised across one funding round. In May 2023, the company promoted Jonny Cline to Chief Operations Officer, signaling a focus on strengthening its operational leadership.

Business overview

Reagenics Research is a dual-platform biotech company specializing in the production of essential molecules. The company leverages various genetic techniques to cultivate high-quality molecules from plant, algae, and mushroom cell tissue. Its core technology involves proprietary bioreactors designed to scale up the production of plant cell biomass, ensuring the security, supply, and quality of these essential molecules. Reagenics Research serves markets within Agriculture & Food Technologies and Health Tech & Life Sciences, focusing on applications in food products, dyes, vitamins, food additives, cosmetics, and pharmaceuticals.

Strategic signal

In July 2023, Reagenics Research announced a novel method for producing commercially viable quantities of cannabinoids and other bioactives via plant cell culture. This development is significant as it addresses challenges in consistent formulation and supply within the cannabis and nutraceutical industries, indicating strong potential for the company to expand its product offerings and market reach through strategic partnerships and further investment.

Company Intelligence Q&A

What is Reagenics Research's core technology?

Reagenics Research utilizes an intelligent bioreactors platform to produce essential plant molecules. This technology allows for the cultivation of high-quality molecules from plant, algae, and mushroom cell tissue, enabling scaled production of plant cell biomass.

What was a key strategic partnership for Reagenics Research in 2023?

In February 2023, Reagenics Research partnered with KND Labs, a manufacturer of nutraceutical ingredients. This collaboration aims to expand KND Labs' product offerings in the global nutraceutical and ingredients marketplace by applying KND Labs' expertise in scaled production to new ingredients provided by Reagenics Research's technology.

What was a significant leadership change at Reagenics Research in 2023?

In May 2023, Reagenics Research promoted Jonny Cline to Chief Operations Officer (COO). Cline previously served as the company's operations and human resources executive vice president, bringing extensive experience in senior roles within the startup and social sectors to his new position.

What progress has Reagenics Research made in cannabinoid production?

In July 2023, Reagenics Research developed a novel method to produce commercially viable quantities of a broad spectrum of cannabinoids from cannabis plant cells. The company is also in discussions with international conglomerates for potential partnerships in this area.

What are Reagenics Research's plans for expansion?

In April 2023, Reagenics Research announced plans to build a bioreactor in Denver, Colorado, following the establishment of bioreactors in Nes Ziona and a pilot plant in the Golan Heights. The company aims to scale its production capabilities for plant cells used in food products, dyes, vitamins, and food additives.